Q:
A:
ALIMS certifies first shipment of H1N1 vaccines
Belgrade,
17 December 2009
Director of the Serbian Medicines and Medical Devices Agency (ALIMS) Tatjana Sipetic signed last evening a certificate of quality for the first shipment of the H1N1 vaccine which confirms that the distribution of the vaccines can begin.
Tatjana Sipetic
Author:
Tanjug
Speaking at a press conference, Sipetic said that the testing of the Novartis H1N1 vaccine verifies that the vaccine reaches specified standards.
She said that the testing was done in accordance with all quality control protocols, adding that the first doses came in for testing on December 2 and the analysis was completed last night at 11pm.
Sipetic said that the vaccine will be available today in all health centres throughout Serbia.
She said that the second shipment of the vaccine arrived in ALIMS for quality control last night, a process that will require 14 days.
She said that the testing was done in accordance with all quality control protocols, adding that the first doses came in for testing on December 2 and the analysis was completed last night at 11pm.
Sipetic said that the vaccine will be available today in all health centres throughout Serbia.
She said that the second shipment of the vaccine arrived in ALIMS for quality control last night, a process that will require 14 days.
From left: Slavko Markovic, Tatjana Sipetic and Ivan Kovacevic
Author:
Tanjug
Director of the national quality control laboratory at ALIMS Slavko Markovic said that the new shipment of vaccines will also be tested as each shipment of medicines entering the country must undergo testing according to law.
Director of the centre for monitoring side effects at ALIMS Ivan Kovacevic said that information will be gathered regarding side effects as the vaccination goes on. He said that WHO has provided a programme for monitoring side effects, adding that all data collected in Serbia will be fed into the WHO data base.
He said that it is very important that health workers are aware that they should report any side effects and to inform ALIMS or the Milan Jovanovic Batut health institute about them directly.
Director of the centre for monitoring side effects at ALIMS Ivan Kovacevic said that information will be gathered regarding side effects as the vaccination goes on. He said that WHO has provided a programme for monitoring side effects, adding that all data collected in Serbia will be fed into the WHO data base.
He said that it is very important that health workers are aware that they should report any side effects and to inform ALIMS or the Milan Jovanovic Batut health institute about them directly.
-
Belgrade, 22 January 2025Egypt one of Serbia’s closest partners on international stage
-
Belgrade, 9 July 2024Support for 104 associations in diaspora that preserve Serbian language, culture
-
Belgrade, 15 April 2024Competition for StarTech grants open until 31 May
-
Belgrade, 2 October 2023Serbia respects Resolution 1244 and will do everything to preserve peace
-
Belgrade, 13 September 2023Day of Serbian Unity to be celebrated outside borders of Serbia, Republika Srpska for the first time
-
Belgrade, 8 August 2023RSD 24.2m in state aid paid out to citizens affected by storm
-
Belgrade, 17 June 2023Belgrade is doing everything to preserve peace in Kosovo and Metohija
-
Belgrade, 15 June 2023Slovenia will continue to support Serbia on its way to EU
-
Belgrade, 5 May 2023Emergency measures, tightening of conditions for possessing weapons
-
Belgrade, 3 May 2023Three days of mourning in Serbia over tragedy at Vladislav Ribnikar primary school